Lisdexamfetamine, marketed as Vyvanse, is a scheduled drug recognized in Canada for managing Attention-Deficit/Hyperactivity Disorder (ADHD) in individuals and people. The medication functions as a prodrug, https://lisdexamfetaminepharmacy966695.opentechblog.com/61991000/vyvanse-in-canada-a-comprehensive-guide